Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

HIV Infection

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 75 articles: HTML format

Single Articles

May 2024
1. GRINSPOON SK, Ribaudo HJ, Douglas PS
   Trial Update of Pitavastatin to Prevent Cardiovascular Events in HIV Infection.
   N Engl J Med. 2024;390:1626-1628.
   PubMed    
   
   
   
2. MEYA DB, Williamson PR
   Cryptococcal Disease in Diverse Hosts.
   N Engl J Med. 2024;390:1597-1610.
   PubMed    
   
   
   February 2024
3. RANDOLPH SD, Johnson R
   A Salon-Based Intervention to Improve PrEP Uptake among Black Women.
   N Engl J Med. 2024;390:776-777.
   PubMed    
   
   
   
4. DICKTER JK, Aribi A, Cardoso AA, Gianella S, et al
   HIV-1 Remission after Allogeneic Hematopoietic-Cell Transplantation.
   N Engl J Med. 2024;390:669-671.
   PubMed    
   
   
   
5. FORD N, Ehrenkranz P, Jarvis J
   Advanced HIV as a Neglected Disease.
   N Engl J Med. 2024;390:487-489.
   PubMed    
   
   
   January 2024
6. DONOVAN J, Phu NH, Thwaites GE
   Dexamethasone for Tuberculous Meningitis in HIV-Positive Adults. Reply.
   N Engl J Med. 2024;390:383.
   PubMed    
   
   
   
7. ELLIS J, Meya DB, Cresswell FC
   Dexamethasone for Tuberculous Meningitis in HIV-Positive Adults.
   N Engl J Med. 2024;390:382-383.
   PubMed    
   
   
   
8. STAFFORD IA, Workowski KA, Bachmann LH
   Syphilis Complicating Pregnancy and Congenital Syphilis.
   N Engl J Med. 2024;390:242-253.
   PubMed    
   
   
   December 2023
9. MARRAZZO J
   Doxycycline Postexposure Prophylaxis for STIs in Women - Uncertain Benefit, Urgent Need.
   N Engl J Med. 2023;389:2389-2390.
   PubMed    
   
   
   
10. STEWART J, Oware K, Donnell D, Violette LR, et al
    Doxycycline Prophylaxis to Prevent Sexually Transmitted Infections in Women.
    N Engl J Med. 2023;389:2331-2340.
    PubMed     Abstract available
    
    
    
11. MOROTI CONSTANTINESCU VR
    Acute Human Immunodeficiency Virus Infection.
    N Engl J Med. 2023;389:2276.
    PubMed    
    
    
    November 2023
12. GRINSPOON SK, Ribaudo HJ, Douglas PS
    Pitavastatin and Cardiovascular Disease in HIV. Reply.
    N Engl J Med. 2023;389:e46.
    PubMed    
    
    
    
13. OLALLA J, Pombo M
    Pitavastatin and Cardiovascular Disease in HIV.
    N Engl J Med. 2023;389:e46.
    PubMed    
    
    
    
14. IOANNOU P, Filippatos TD, Kofteridis DP
    Pitavastatin and Cardiovascular Disease in HIV.
    N Engl J Med. 2023;389:e46.
    PubMed    
    
    
    
15. ALAM SR, Mureithi M, Ferrand R
    Pitavastatin and Cardiovascular Disease in HIV.
    N Engl J Med. 2023;389:e46.
    PubMed    
    
    
    
16. BOETTIGER DC, Phillips AN, Newall AT
    Pitavastatin and Cardiovascular Disease in HIV.
    N Engl J Med. 2023;389:e46.
    PubMed    
    
    
    October 2023
17. DONOVAN J, Bang ND, Imran D, Nghia HDT, et al
    Adjunctive Dexamethasone for Tuberculous Meningitis in HIV-Positive Adults.
    N Engl J Med. 2023;389:1357-1367.
    PubMed     Abstract available
    
    
    September 2023
18. ABDOOL KARIM SS, Barre-Sinoussi F, Varmus HE, Serwadda D, et al
    Threatening the Global AIDS Response - Obstacles to PEPFAR's Reauthorization.
    N Engl J Med. 2023;389:1159-1161.
    PubMed    
    
    
    August 2023
19. LO NC, Gonsalves GS
    Outbreaks in U.S. Migrant Detention Centers - A Vaccine-Preventable Cause of Health Inequity.
    N Engl J Med. 2023;389:679-681.
    PubMed    
    
    
    
20. 
    Preventing HIV's Collateral Cardiovascular Damage.
    N Engl J Med. 2023;389:e11.
    PubMed    
    
    
    
21. GODFREY C, Nkengasong J
    Prioritizing Mental Health in the HIV/AIDS Response in Africa.
    N Engl J Med. 2023;389:581-583.
    PubMed    
    
    
    
22. KRAKOWER D, Marcus JL
    Free the PrEP - Over-the-Counter Access to HIV Preexposure Prophylaxis.
    N Engl J Med. 2023 Aug 5. doi: 10.1056/NEJMp2305644.
    PubMed    
    
    
    July 2023
23. GRINSPOON SK, Fitch KV, Zanni MV, Fichtenbaum CJ, et al
    Pitavastatin to Prevent Cardiovascular Disease in HIV Infection.
    N Engl J Med. 2023 Jul 23. doi: 10.1056/NEJMoa2304146.
    PubMed     Abstract available
    
    
    
24. FREIBERG MS
    HIV and Cardiovascular Disease - An Ounce of Prevention.
    N Engl J Med. 2023 Jul 23. doi: 10.1056/NEJMe2306782.
    PubMed    
    
    
    
25. NACHEGA JB, Serwadda D, Abimiku A, Sikazwe I, et al
    PEPFAR at 20 - A Game-Changing Impact on HIV in Africa.
    N Engl J Med. 2023;389:1-4.
    PubMed    
    
    
    June 2023
26. OMBAJO LA, Penner J, Nkuranga J, Mecha J, et al
    Second-Line Switch to Dolutegravir for Treatment of HIV Infection.
    N Engl J Med. 2023;388:2349-2359.
    PubMed     Abstract available
    
    
    
27. OGOINA D, James HI
    Mpox among Linked Heterosexual Casual Partners in Bayelsa, Nigeria.
    N Engl J Med. 2023;388:2101-2104.
    PubMed    
    
    
    May 2023
28. DEPUTY NP, Deckert J, Chard AN, Sandberg N, et al
    Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States.
    N Engl J Med. 2023 May 18. doi: 10.1056/NEJMoa2215201.
    PubMed     Abstract available
    
    
    
29. LISCO A, Ortega-Villa AM, Mystakelis H, Anderson MV, et al
    Reappraisal of Idiopathic CD4 Lymphocytopenia at 30 Years.
    N Engl J Med. 2023;388:1680-1691.
    PubMed     Abstract available
    
    
    April 2023
30. LUETKEMEYER AF, Donnell D, Dombrowski JC, Cohen S, et al
    Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections.
    N Engl J Med. 2023;388:1296-1306.
    PubMed     Abstract available
    
    
    March 2023
31. 
    The Fauci Phenomenon, Part 2.
    N Engl J Med. 2023;388:e40.
    PubMed    
    
    
    
32. 
    The Fauci Phenomenon.
    N Engl J Med. 2023;388:e28.
    PubMed    
    
    
    
33. JOHNSON J, Killelea A, Farrow K
    Investing in National HIV PrEP Preparedness.
    N Engl J Med. 2023;388:769-771.
    PubMed    
    
    
    February 2023
34. PATON NI, Cousins C, Suresh C, Burhan E, et al
    Treatment Strategy for Rifampin-Susceptible Tuberculosis.
    N Engl J Med. 2023 Feb 20. doi: 10.1056/NEJMoa2212537.
    PubMed     Abstract available
    
    
    January 2023
35. EKE AC, Mirochnick M, Lockman S
    Antiretroviral Therapy and Adverse Pregnancy Outcomes in People Living with HIV.
    N Engl J Med. 2023;388:344-356.
    PubMed    
    
    
    December 2022
36. NYANG'WA BT, Berry C, Kazounis E, Motta I, et al
    A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis.
    N Engl J Med. 2022;387:2331-2343.
    PubMed     Abstract available
    
    
    
37. KIEH M, Richert L, Beavogui AH, Grund B, et al
    Randomized Trial of Vaccines for Zaire Ebola Virus Disease.
    N Engl J Med. 2022 Dec 14. doi: 10.1056/NEJMoa2200072.
    PubMed     Abstract available
    
    
    November 2022
38. AKIYAMA MJ, Spaulding AC, Nijhawan AE
    Long-Acting Injectable Antiretrovirals in Incarcerated Populations - Challenges and Opportunities.
    N Engl J Med. 2022;387:1728-1730.
    PubMed    
    
    
    
39. CHEMAITELLY H, AlMukdad S, Ayoub HH, Altarawneh HN, et al
    Covid-19 Vaccine Protection among Children and Adolescents in Qatar.
    N Engl J Med. 2022 Nov 2. doi: 10.1056/NEJMoa2210058.
    PubMed     Abstract available
    
    
    September 2022
40. COLLIE S, Nayager J, Bamford L, Bekker LG, et al
    Effectiveness and Durability of the BNT162b2 Vaccine against Omicron Sublineages in South Africa.
    N Engl J Med. 2022 Sep 14. doi: 10.1056/NEJMc2210093.
    PubMed    
    
    
    
41. ANDERSON AS, Caubel P, Rusnak JM
    Nirmatrelvir-Ritonavir and Viral Load Rebound in Covid-19.
    N Engl J Med. 2022 Sep 7. doi: 10.1056/NEJMc2205944.
    PubMed    
    
    
    
42. CONRADIE F, Bagdasaryan TR, Borisov S, Howell P, et al
    Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis.
    N Engl J Med. 2022;387:810-823.
    PubMed     Abstract available
    
    
    
43. PATEL K, Huo Y, Jao J, Powis KM, et al
    Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United States.
    N Engl J Med. 2022;387:799-809.
    PubMed     Abstract available
    
    
    August 2022
44. MARCUS JL, Killelea A, Krakower DS
    HIV Prevention and the 340B Drug Pricing Program. Reply.
    N Engl J Med. 2022;387:576.
    PubMed    
    
    
    
45. HALL CS
    HIV Prevention and the 340B Drug Pricing Program.
    N Engl J Med. 2022;387:575-576.
    PubMed    
    
    
    July 2022
46. THORNHILL JP, Barkati S, Walmsley S, Rockstroh J, et al
    Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022.
    N Engl J Med. 2022 Jul 21. doi: 10.1056/NEJMoa2207323.
    PubMed     Abstract available
    
    
    June 2022
47. PALEFSKY JM, Lee JY, Jay N, Goldstone SE, et al
    Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer.
    N Engl J Med. 2022;386:2273-2282.
    PubMed     Abstract available
    
    
    
48. ALTARAWNEH HN, Chemaitelly H, Ayoub HH, Tang P, et al
    Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections.
    N Engl J Med. 2022 Jun 15. doi: 10.1056/NEJMoa2203965.
    PubMed     Abstract available
    
    
    
49. MARCUS JL, Killelea A, Krakower DS
    Perverse Incentives - HIV Prevention and the 340B Drug Pricing Program.
    N Engl J Med. 2022;386:2064-2066.
    PubMed    
    
    
    May 2022
50. MARRAZZO J
    Lenacapavir for HIV-1 - Potential Promise of a Long-Acting Antiretroviral Drug.
    N Engl J Med. 2022;386:1848-1849.
    PubMed    
    
    
    
51. SEGAL-MAURER S, DeJesus E, Stellbrink HJ, Castagna A, et al
    Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection.
    N Engl J Med. 2022;386:1793-1803.
    PubMed     Abstract available
    
    
    
52. GRAY G, Collie S, Goga A, Garrett N, et al
    Effectiveness of Ad26.COV2.S and BNT162b2 Vaccines against Omicron Variant in South Africa.
    N Engl J Med. 2022 May 4. doi: 10.1056/NEJMc2202061.
    PubMed    
    
    
    April 2022
53. MOORE PL, Baden LR
    Omicron - Decoupling Infection from Severe Disease.
    N Engl J Med. 2022;386:1361-1362.
    PubMed    
    
    
    March 2022
54. JARVIS JN, Lawrence DS, Meya DB, Kagimu E, et al
    Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis.
    N Engl J Med. 2022;386:1109-1120.
    PubMed     Abstract available
    
    
    
55. LUEKING R, Lazarte S
    Malignant Syphilis.
    N Engl J Med. 2022;386:e26.
    PubMed    
    
    
    
56. OZELO MC, Mahlangu J, Pasi KJ, Giermasz A, et al
    Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A.
    N Engl J Med. 2022;386:1013-1025.
    PubMed     Abstract available
    
    
    
57. TURKOVA A, Wills GH, Wobudeya E, Chabala C, et al
    Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children.
    N Engl J Med. 2022;386:911-922.
    PubMed     Abstract available
    
    
    
58. ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, AlMukdad S, et al
    Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar.
    N Engl J Med. 2022 Mar 9. doi: 10.1056/NEJMoa2200797.
    PubMed     Abstract available
    
    
    February 2022
59. SILVERMAN RF, Shinder R
    Molluscum Contagiosum.
    N Engl J Med. 2022;386:582.
    PubMed    
    
    
    January 2022
60. ATMAR RL, Lyke KE, Deming ME, Jackson LA, et al
    Homologous and Heterologous Covid-19 Booster Vaccinations.
    N Engl J Med. 2022 Jan 26. doi: 10.1056/NEJMoa2116414.
    PubMed     Abstract available
    
    
    December 2021
61. TURKOVA A, White E, Mujuru HA, Kekitiinwa AR, et al
    Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children.
    N Engl J Med. 2021;385:2531-2543.
    PubMed     Abstract available
    
    
    
62. COLLIE S, Champion J, Moultrie H, Bekker LG, et al
    Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa.
    N Engl J Med. 2021 Dec 29. doi: 10.1056/NEJMc2119270.
    PubMed    
    
    
    
63. CATTAMANCHI A, Reza TF, Nalugwa T, Adams K, et al
    Multicomponent Strategy with Decentralized Molecular Testing for Tuberculosis.
    N Engl J Med. 2021;385:2441-2450.
    PubMed     Abstract available
    
    
    
64. BOR J, Onoya D, Richman B, Mayer KH, et al
    A Failure to Disseminate Transformative Science - HIV Treatment as Prevention, 10 Years On.
    N Engl J Med. 2021;385:2305-2307.
    PubMed    
    
    
    
65. BRAVO MS
    Emperor of the Empire.
    N Engl J Med. 2021;385:2215-2217.
    PubMed    
    
    
    November 2021
66. DIETZ BW, Winston LG, Koehler JE, Margaretten M, et al
    Copycat.
    N Engl J Med. 2021;385:1797-1802.
    PubMed    
    
    
    October 2021
67. TSENG ZH, Hsue PY, Moffatt E
    Sudden Cardiac Death and Myocardial Fibrosis in Persons with HIV. Reply.
    N Engl J Med. 2021;385:e50.
    PubMed    
    
    
    
68. OLALLA J, Pombo M
    Sudden Cardiac Death and Myocardial Fibrosis in Persons with HIV.
    N Engl J Med. 2021;385:e50.
    PubMed    
    
    
    
69. KLEIN MD, Keen SK, Simpson RJ Jr
    Sudden Cardiac Death and Myocardial Fibrosis in Persons with HIV.
    N Engl J Med. 2021;385:e50.
    PubMed    
    
    
    
70. CHEMAITELLY H, Tang P, Hasan MR, AlMukdad S, et al
    Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar.
    N Engl J Med. 2021 Oct 6. doi: 10.1056/NEJMoa2114114.
    PubMed     Abstract available
    
    
    September 2021
71. SAAG MS
    HIV Infection - Screening, Diagnosis, and Treatment. Reply.
    N Engl J Med. 2021;385:1344.
    PubMed    
    
    
    
72. DE SOCIO GV
    HIV Infection - Screening, Diagnosis, and Treatment.
    N Engl J Med. 2021;385:1344.
    PubMed    
    
    
    
73. LEINER S
    HIV Infection - Screening, Diagnosis, and Treatment.
    N Engl J Med. 2021;385:1343-1344.
    PubMed    
    
    
    
74. BAYER R, Oppenheimer GM, Parisi V
    Marking the 40th Anniversary of the AIDS Epidemic - American Physicians Look Back.
    N Engl J Med. 2021;385:1251-1253.
    PubMed    
    
    
    
75. GOUVEIA-MORAES F, Campos N
    Conjunctival Kaposi's Sarcoma.
    N Engl J Med. 2021;385:e36.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.